TAM inhibits PA progression by inducing apoptosis and expression changes of apoptosis-related proteins, and reprogramming tumor-associated macrophages to the M1 phenotype via STAT6 inactivation and SHP1/SHP2 blockade. Here, NR0B2 is linked to neoplasm.